Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir.
Unemori
Patrick
P
Leslie
Kieron S
KS
Maurer
Toby
T
D000284:Administration, Oral; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001706:Biopsy; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006679:HIV Seropositivity / Q000150:complications* / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011536:Prurigo / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D011760:Pyrrolidinones / Q000008:administration & dosage*; D000068898:Raltegravir Potassium; D012867:Skin / Q000473:pathology
D019380:Anti-HIV Agents; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium